10-K Decoder · All companies

Arbutus Biopharma Corporation

ABUS · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Mar 2026

Open the dashboardInfographicSummary

FY2025 key figures

$FY2025FY2024Change
Revenue$14.1M$6.17M+128%
Operating income−$38.2M−$76.3M+50.0%
Net income−$33.5M−$69.9M+52.1%

Latest quarter: Q3 2026

Form 10-Q · Three months ended Sep 30, 2026 · filed Nov 10, 2026

$Q3 2026Year earlierChange
Revenue$300K$500K−40.0%
Operating income−$10.5M−$8.70M−20.7%
Net income$59.1M−$7.70M

Q3 2026 dashboardQ3 2026 infographic

Questions

What was Arbutus's revenue in FY2025?
$14.1M in FY2025 (Fiscal year ended Dec 31, 2025), +128% vs $6.17M a year earlier, per its 10-K filed Mar 2026.
Was Arbutus profitable in FY2025?
No: net income was −$33.5M and operating income −$38.2M in FY2025.
What was Arbutus's revenue in Q3 2026?
$300K (−40.0% vs a year earlier), per its Form 10-Q filed Nov 10, 2026.